Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Exchange Rate Effect of -$1.4 million for Q1 2026, down 143.84% on a YoY basis from $3.1 million in Q1 2025, and down 423.44% quarter-over-quarter from $418000.0 in Q4 2025.
Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported Exchange Rate Effect for 7 years, with the latest figure at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 143.84% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 65.72% YoY), and the FY2025 full-year result was $7.0 million, up 447.01% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1.4 million, down from $418000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $6.2 million in Q3 2024, with the low at -$7.3 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $352823.5 across 5 years, with a median of $418000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 1604.17% — and 2024, when it plunged 754.81%.
- Barinthus Biotherapeutics' Exchange Rate Effect stood at $5.7 million in 2022, then plunged by 80.41% to $1.1 million in 2023, then plunged by 754.81% to -$7.3 million in 2024, then soared by 105.69% to $418000.0 in 2025, then slumped by 423.44% to -$1.4 million in 2026.
- The last three Exchange Rate Effect figures came in at -$1.4 million (Q1 2026), $418000.0 (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | -1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Mn |
| Mar 31, 2026 | -1.35 Mn |
| Dec 31, 2025 | 418,000.00 |
| Dec 31, 2025 | 418,000.00 |
| Sep 30, 2025 | -1.84 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Dec 31, 2024 | -7.35 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | -357,000.00 |
| Jun 30, 2024 | -357,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Dec 31, 2023 | 1.12 Mn |
| Dec 31, 2023 | 1.12 Mn |